491 related articles for article (PubMed ID: 26311408)
1. Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.
Di Marco LY; Venneri A; Farkas E; Evans PC; Marzo A; Frangi AF
Neurobiol Dis; 2015 Oct; 82():593-606. PubMed ID: 26311408
[TBL] [Abstract][Full Text] [Related]
2. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.
Zhao Y; Gong CX
Cell Mol Neurobiol; 2015 Jan; 35(1):101-10. PubMed ID: 25352419
[TBL] [Abstract][Full Text] [Related]
3. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
4. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress.
Liu H; Zhang J
Int J Neurosci; 2012 Sep; 122(9):494-9. PubMed ID: 22519891
[TBL] [Abstract][Full Text] [Related]
5. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
6. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
Winkler EA; Nishida Y; Sagare AP; Rege SV; Bell RD; Perlmutter D; Sengillo JD; Hillman S; Kong P; Nelson AR; Sullivan JS; Zhao Z; Meiselman HJ; Wendy RB; Soto J; Abel ED; Makshanoff J; Zuniga E; De Vivo DC; Zlokovic BV
Nat Neurosci; 2015 Apr; 18(4):521-530. PubMed ID: 25730668
[TBL] [Abstract][Full Text] [Related]
7. Reduction in pericyte coverage leads to blood-brain barrier dysfunction via endothelial transcytosis following chronic cerebral hypoperfusion.
Sun Z; Gao C; Gao D; Sun R; Li W; Wang F; Wang Y; Cao H; Zhou G; Zhang J; Shang J
Fluids Barriers CNS; 2021 May; 18(1):21. PubMed ID: 33952281
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer's disease.
Toda N; Okamura T
J Pharmacol Sci; 2016 Aug; 131(4):223-32. PubMed ID: 27530818
[TBL] [Abstract][Full Text] [Related]
9. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
10. The pericyte: a forgotten cell type with important implications for Alzheimer's disease?
Winkler EA; Sagare AP; Zlokovic BV
Brain Pathol; 2014 Jul; 24(4):371-86. PubMed ID: 24946075
[TBL] [Abstract][Full Text] [Related]
11. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
12. Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
He JT; Zhao X; Xu L; Mao CY
J Alzheimers Dis; 2020; 73(1):39-58. PubMed ID: 31815697
[TBL] [Abstract][Full Text] [Related]
13. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
14. Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
Di Marco LY; Farkas E; Martin C; Venneri A; Frangi AF
J Alzheimers Dis; 2015; 46(1):35-53. PubMed ID: 25720414
[TBL] [Abstract][Full Text] [Related]
15. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.
Grammas P
J Neuroinflammation; 2011 Mar; 8():26. PubMed ID: 21439035
[TBL] [Abstract][Full Text] [Related]
16. Obesity-induced cerebral hypoperfusion derived from endothelial dysfunction: one of the risk factors for Alzheimer's disease.
Toda N; Ayajiki K; Okamura T
Curr Alzheimer Res; 2014; 11(8):733-44. PubMed ID: 25212912
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension.
Santisteban MM; Ahn SJ; Lane D; Faraco G; Garcia-Bonilla L; Racchumi G; Poon C; Schaeffer S; Segarra SG; Körbelin J; Anrather J; Iadecola C
Hypertension; 2020 Sep; 76(3):795-807. PubMed ID: 32654560
[TBL] [Abstract][Full Text] [Related]
18. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging.
Toth P; Tarantini S; Csiszar A; Ungvari Z
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H1-H20. PubMed ID: 27793855
[TBL] [Abstract][Full Text] [Related]
19. Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
Tarantini S; Tran CHT; Gordon GR; Ungvari Z; Csiszar A
Exp Gerontol; 2017 Aug; 94():52-58. PubMed ID: 27845201
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.
Zlokovic BV
Nat Rev Neurosci; 2011 Nov; 12(12):723-38. PubMed ID: 22048062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
